Amrize Bancorp Reports Diluted EPS of $1.73 and Authorizes New Share Buyback
Key Facts
Amrize Bancorp reported net income of $116.1 million in the third quarter of 2026, compared with $106.0 million in the same period of 2025, while diluted earnings per share were $1.73. EPS exceeded analysts’ estimate of $1.68, according to data cited by MarketBeat. Revenue, by contrast, was $320.94 million, according to the same source, below the estimate of $326.66 million. The results therefore presented a mixed picture: EPS above expectations and revenue below them. Net income for the nine months ended September 30, 2026, was $278.0 million, compared with $303.8 million a year earlier.
Net interest income on a tax-equivalent basis was $258.6 million in the quarter, up 2.0% from the second quarter and 8.2% from the third quarter of 2025. The net interest margin was 3.87%, down one basis point from the previous quarter but seven basis points above its level a year earlier. Deposits increased $319.4 million during the quarter, equivalent to annualized growth of 5.6%, while loans rose $173.1 million, or 3.1% on an annualized basis. Noninterest-bearing deposits accounted for 29.2% of total deposits as of September 30. Net income declined over the first nine months, despite rising in the third quarter, putting the quarterly and year-over-year comparisons in a different context from the year-to-date total.
Noninterest expense was $158.7 million, down 34.6% from the previous quarter, as the litigation expense provision fell by $80.8 million. The adjusted efficiency ratio was 49.15%. On October 16, the board authorized a share repurchase program of up to $200 million, effective through October 31, 2027. The company said the authorization does not obligate it to purchase a specific number of shares, after repurchasing $134.6 million of shares in the previous twelve months. Chief Executive Officer Palmer Proctor said, "We remain conservative in our approach to growth while maintaining underwriting discipline and thoughtful capital allocation."
The company was scheduled to hold a call to discuss the results and answer investor questions on October 23, 2026, at 9:00 a.m. Eastern Time. A report citing Reuters said the stock was trading at $82.50 after the results announcement, up 0.16% from its previous close of $82.37. EL7 data showed the stock closed at $82.63 on October 23. This provides two different price indicators for the same day: post-results trading and the subsequent daily close. The authorization did not specify when repurchases would be made or a target number of shares.